> top > docs > PMC:7597510 > spans > 1025-2786 > annotations

PMC:7597510 / 1025-2786 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid_Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 873-876 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T2 873-876 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T3 883-887 https://glytoucan.org/Structures/Glycans/G17077FL denotes GQ1b
T4 883-887 https://glytoucan.org/Structures/Glycans/G18625KA denotes GQ1b
T5 897-901 https://glytoucan.org/Structures/Glycans/G37184KW denotes GD1b
T6 897-901 https://glytoucan.org/Structures/Glycans/G97612UN denotes GD1b

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T4 236-247 Body_part denotes glycolipids http://purl.org/sig/ont/fma/fma82780
T5 256-267 Body_part denotes ganglioside http://purl.org/sig/ont/fma/fma82816
T6 777-785 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T18 0-23 Disease denotes Guillain-Barré syndrome http://purl.obolibrary.org/obo/MONDO_0016218
T19 25-28 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T20 50-72 Disease denotes polyradiculoneuropathy http://purl.obolibrary.org/obo/MONDO_0006915
T21 118-127 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T22 170-173 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T23 198-207 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T24 423-426 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T25 443-451 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T26 454-463 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T27 593-601 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T28 604-613 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T29 622-625 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T30 949-957 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T31 960-969 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T32 981-984 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T33 997-1044 Disease denotes acute inflammatory demyelinating polyneuropathy http://purl.obolibrary.org/obo/MONDO_0016218
T34 1016-1044 Disease denotes demyelinating polyneuropathy http://purl.obolibrary.org/obo/MONDO_0003334
T35 1030-1044 Disease denotes polyneuropathy http://purl.obolibrary.org/obo/MONDO_0001824
T36 1051-1092 Disease denotes Acute motor and sensory axonal neuropathy http://purl.obolibrary.org/obo/MONDO_0020348
T37 1075-1092 Disease denotes axonal neuropathy http://purl.obolibrary.org/obo/MONDO_0004183
T38 1082-1092 Disease denotes neuropathy http://purl.obolibrary.org/obo/MONDO_0005244
T39 1097-1126 Disease denotes acute motor axonal neuropathy http://purl.obolibrary.org/obo/MONDO_0020349
T40 1109-1126 Disease denotes axonal neuropathy http://purl.obolibrary.org/obo/MONDO_0004183
T41 1116-1126 Disease denotes neuropathy http://purl.obolibrary.org/obo/MONDO_0005244
T42 1232-1235 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T43 1252-1260 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T44 1263-1272 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T45 1379-1387 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T46 1390-1399 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T47 1408-1411 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T48 1642-1650 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T49 1653-1662 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T50 1671-1674 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T51 1750-1760 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T5 569-570 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T6 839-844 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T7 913-917 http://purl.obolibrary.org/obo/CLO_0001406 denotes 5–14
T8 1210-1211 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T9 1296-1302 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 236-247 Chemical denotes glycolipids http://purl.obolibrary.org/obo/CHEBI_33563
T2 256-267 Chemical denotes ganglioside http://purl.obolibrary.org/obo/CHEBI_28892
T3 873-876 Chemical denotes GM1 http://purl.obolibrary.org/obo/CHEBI_18216|http://purl.obolibrary.org/obo/CHEBI_61048|http://purl.obolibrary.org/obo/CHEBI_73110
T6 883-887 Chemical denotes GQ1b http://purl.obolibrary.org/obo/CHEBI_27515
T7 897-901 Chemical denotes GD1b http://purl.obolibrary.org/obo/CHEBI_28175
T8 1701-1703 Chemical denotes IV http://purl.obolibrary.org/obo/CHEBI_74327
T9 1704-1709 Chemical denotes gamma http://purl.obolibrary.org/obo/CHEBI_30212

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
45 1284-1291 Species denotes patient Tax:9606
46 1730-1738 Species denotes patients Tax:9606
47 256-267 Chemical denotes ganglioside MESH:D005732
48 873-876 Chemical denotes GM1 MESH:D005677
49 50-72 Disease denotes polyradiculoneuropathy MESH:D011129
50 118-127 Disease denotes infection MESH:D007239
51 198-207 Disease denotes infection MESH:D007239
52 443-463 Disease denotes SARS-CoV-2 infection MESH:C000657245
53 593-613 Disease denotes SARS-CoV-2-infection MESH:C000657245
54 949-969 Disease denotes SARS-CoV-2-infection MESH:C000657245
55 1016-1044 Disease denotes demyelinating polyneuropathy MESH:D003711
56 1067-1092 Disease denotes sensory axonal neuropathy MESH:C536450
57 1097-1126 Disease denotes acute motor axonal neuropathy MESH:D000208
58 1252-1272 Disease denotes SARS-CoV-2 infection MESH:C000657245
59 1379-1399 Disease denotes SARS-CoV-2-infection MESH:C000657245
60 1642-1662 Disease denotes SARS-CoV-2-infection MESH:C000657245
61 1750-1760 Disease denotes thrombosis MESH:D013927

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T2 1016-1029 Phenotype denotes demyelinating http://purl.obolibrary.org/obo/HP_0011096
T3 1030-1044 Phenotype denotes polyneuropathy http://purl.obolibrary.org/obo/HP_0001271
T4 1067-1092 Phenotype denotes sensory axonal neuropathy http://purl.obolibrary.org/obo/HP_0003390
T5 1103-1126 Phenotype denotes motor axonal neuropathy http://purl.obolibrary.org/obo/HP_0007002

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T11 0-144 Sentence denotes Guillain-Barré syndrome (GBS) is an acute type of polyradiculoneuropathy, that occurs following immune events such as infection and vaccination.
T12 145-314 Sentence denotes Approximately 40%–70% of GBS cases develop following infection, and autoantibodies against glycolipids (mainly ganglioside antibodies) are detected in over 50% of cases.
T13 315-477 Sentence denotes The cause is generally accepted to be an abnormality in the immune process.1 2 Recently, several reports of GBS associated with SARS-CoV-2 infection have emerged.
T14 478-1050 Sentence denotes However, as far as we have investigated, there are still no reports in Japan.3 However, in a review of 37 cases of SARS-CoV-2-infection-related GBS, less than half of the studies investigated antiganglioside antibodies.4 Furthermore, few reports have provided details related to the antiganglioside antibody investigated, and clear descriptions of the relevant tests are available only for anti-GM1, anti-GQ1b and anti-GD1b antibodies.5–14 Most reported cases (64.8%) of SARS-CoV-2-infection-associated GBS were of the acute inflammatory demyelinating polyneuropathy type.
T15 1051-1342 Sentence denotes Acute motor and sensory axonal neuropathy and acute motor axonal neuropathy types were observed in 13.5% and 2.7% of cases.4 In the present report, we discuss a case of axonal-type GBS associated with SARS-CoV-2 infection, where the patient was tested for various antiganglioside antibodies.
T16 1343-1543 Sentence denotes Furthermore, we review the cases of SARS-CoV-2-infection-related GBS reported to date, in order to provide insight into the clinical characteristics and pathological mechanisms underlying the disease.
T17 1544-1761 Sentence denotes Our report also highlights the need for clinicians to remain cautious when attempting to diagnose SARS-CoV-2-infection-related GBS, and when using high-dose IV gamma globulin therapy in patients at risk of thrombosis.

LitCovid-PD-GlycoEpitope

Id Subject Object Predicate Lexical cue glyco_epitope_db_id
T1 868-876 GlycoEpitope denotes anti-GM1 http://www.glycoepitope.jp/epitopes/AN0713
T2 873-876 GlycoEpitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T3 883-887 GlycoEpitope denotes GQ1b http://www.glycoepitope.jp/epitopes/EP0069
T4 892-901 GlycoEpitope denotes anti-GD1b http://www.glycoepitope.jp/epitopes/AN0403
T5 897-901 GlycoEpitope denotes GD1b http://www.glycoepitope.jp/epitopes/EP0059